Reuters logo
BRIEF-Aerie Pharmaceuticals enters into controlled equity offering sales agreement with Cantor Fitzgerald
May 25, 2017 / 10:24 AM / in 7 months

BRIEF-Aerie Pharmaceuticals enters into controlled equity offering sales agreement with Cantor Fitzgerald

May 25 (Reuters) - Aerie Pharmaceuticals Inc

* Aerie Pharmaceuticals - on May 25, co entered into controlled equity offering sales agreement with Cantor Fitzgerald & Co. - SEC filing

* Aerie Pharmaceuticals - under agreement co may offer and sell shares of common stock, having an aggregate offering price of up to $50 million Source: (bit.ly/2qfDRUj) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below